Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation

Nielsen, 2013, Tumor necrosis factor inhibitors for inflammatory bowel disease, N. Engl. J. Med., 369, 754, 10.1056/NEJMct1209614 Geremia, 2014, Innate and adaptive immunity in inflammatory bowel disease, Autoimmun. Rev., 13, 3, 10.1016/j.autrev.2013.06.004 Rosenstiel, 2013, Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine, Curr. Opin. Gastroenterol., 29, 125, 10.1097/MOG.0b013e32835da2c7 Cader, 2013, Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation, Gut, 62, 1653, 10.1136/gutjnl-2012-303955 Shibolet, 2007, TLRs in the gut. IV. Negative regulation of toll-like receptors and intestinal homeostasis: addition by subtraction, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G1469, 10.1152/ajpgi.00531.2006 Kawai, 2011, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity, Immunity, 34, 637, 10.1016/j.immuni.2011.05.006 Cario, 2010, Toll-like receptors in inflammatory bowel diseases: a decade later, Inflamm. Bowel Dis., 16, 1583, 10.1002/ibd.21282 Abreu, 2005, TLR signaling in the gut in health and disease, J. Immunol., 174, 4453, 10.4049/jimmunol.174.8.4453 Uematsu, 2006, Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells, Nat. Immunol., 7, 868, 10.1038/ni1362 Riva, 2012, TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity, Front. Immunol., 3, 322, 10.3389/fimmu.2012.00322 Wang, 2011, Recent advances of chitosan nanoparticles as drug carriers, Int. J. Nanomed., 6, 765 Murano, 2000, Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis, Clin. Exp. Immunol., 120, 51, 10.1046/j.1365-2249.2000.01183.x Dieleman, 1998, Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines, Clin. Exp. Immunol., 114, 385, 10.1046/j.1365-2249.1998.00728.x Wald, 2003, SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling, Nat. Immunol., 4, 920, 10.1038/ni968 Garlanda, 2004, Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family, Proc. Natl. Acad. Sci. U. S. A., 101, 3522, 10.1073/pnas.0308680101 Zhao, 2015, Human colon tumors express a dominant-negative form of SIGIRR that promotes inflammation and colitis-associated colon cancer in mice, Gastroenterology, 149, 1860, 10.1053/j.gastro.2015.08.051 Kadota, 2010, Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation, Clin. Exp. Immunol., 162, 348, 10.1111/j.1365-2249.2010.04254.x Jabbal-Gill, 2012, Chitosan-based delivery systems for mucosal vaccines, Expert Opin. Drug Deliv., 9, 1051, 10.1517/17425247.2012.697455 Takedatsu, 2015, Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease, World J. Gastroenterol., 21, 11343, 10.3748/wjg.v21.i40.11343 Gulbake, 2012, Chitosan: a potential polymer for colon-specific drug delivery system, Expert Opin. Drug Deliv., 9, 713, 10.1517/17425247.2012.682148 Martirosyan, 2014, Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics, Adv. Genet., 88, 325, 10.1016/B978-0-12-800148-6.00011-0 Prabaharan, 2015, Chitosan-based nanoparticles for tumor-targeted drug delivery, Int. J. Biol. Macromol., 72, 1313, 10.1016/j.ijbiomac.2014.10.052